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n Abstract
Objectives: In this multicenter survey, we assessed the impact of sensitization to cypress in atopic patients in Italy and determined whether 
cypress pollen concentration changed over time. 
Methods: Allergists were required to collect the results of 100-200 consecutive skin prick tests (SPTs) performed during 2012. Seasonal 
symptoms were also recorded, as were airborne cypress pollen concentrations (data from the Italian Aerobiology Association) in 1998-
2000 and 2010-2012. 
Results: We examined 2258 atopic outpatients (56% females; age, 2-84 years) sensitized to at least 1 of the aeroallergens tested 
(Dermatophagoides species, grass, pellitory, olive, cypress, birch, Alternaria tenuis, and dog and cat dander). We found that 62.9%, 16.1%, 
and 32.7% of patients living in central, northern, and southern Italy, respectively, were sensitized to cypress (P<.0001). The cypress 
pollen concentration peak was delayed from February to March in 1998-2000 and 2010-2012 in all 3 regions, with a shift in pollination 
towards spring. Patients who were monosensitized to cypress reported mainly rhinitis (90.7%-97.6%) and conjunctivitis (38.1%-100%). 
In polysensitized patients, the prevalence of rhinitis, conjunctivitis, and asthma increased progressively (P<.0001) from southern to northern 
Italy. The same trend was observed for the prevalence of reported winter symptoms typical of cypress allergy (28%-65%). 
Conclusions: Today, cypress pollen is the most frequent sensitizing aeroallergen (assessed by SPT) in several areas of central Italy. Variations 
in the timing of the cypress pollination period may have favored this increased sensitization. Rhinitis and conjunctivitis are the predominant 
symptoms. The clinical impact of this allergy was poor in southern Italy and increased in central areas before reaching its peak in northern regions.
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Introduction
The prevalence of sensitization to cypress (assessed 
using skin prick test [SPT]) has increased progressively in 
the Mediterranean area in the last 20-30 years, particularly 
in some regions of Italy [1,2]. The possible explanations for 
this increase include improved diagnostic techniques (better 
and more routinely used extracts), increased concentrations of 
airborne pollen (during the pollen season), and widespread use 
of cypress in parks and gardens [1]. In 2000, an Italian study 
to detect the prevalence of sensitization to cypress in Italy 
found that prevalence had increased over the years and that 
the distribution between northern, central, and southern Italy 
had changed [3]. Prevalence was higher in central Italy than in 
southern Italy and very low in northern areas. In the last 6 years, 
only 2 studies have evaluated the prevalence of sensitization to 
cypress in 2 restricted areas of Italy (Maremma [Tuscany] and 
Apulia) [4,5]. Both showed that the prevalence of sensitization 
to this allergen was greater than that of sensitization to other 
allergens (grass, pellitory, olive, and other trees). Therefore, 
we believe that sensitization to cypress has increased in recent 
years in Italy. We investigated the prevalence of sensitization to 
cypress detected by SPT in Italy in 2012. We also evaluated the 
clinical impact of sensitization on symptoms and investigated 
trends in cypress pollen concentrations since 1998. 
Materials and Methods
Data were obtained from 13 outpatient clinics uniformly 
distributed in different Italian areas. The results of at least 
100-200 consecutive positive SPTs performed in 2012 were 
analyzed. Data were also collected on symptoms and the 
seasons when the symptoms appeared. All patients underwent 
SPT because they had reported suspected allergic respiratory 
and/or ocular symptoms (conjunctivitis, rhinitis, coughing, 
dyspnea, and wheezing). We analyzed 2258 outpatients (56% 
females; age, 2-84 years) who were sensitized to at least 1 
of the most common aeroallergens tested. The commercial 
allergen extracts used in the SPTs were provided by ALK 
Abelló Group. The extracts were from Dermatophagoides 
pteronyssinus and Dermatophagoides farinae, grass mix, 
Parietaria, Olea europaea, Cupressus sempervirens, Betula 
pendula, Alternaria tenuis, and dog-cat dander. SPTs were 
carried out and interpreted according to international 
guidelines [6]. All centers followed the same protocol and 
provided the SPT results obtained. Patients with infectious 
diseases, malignancies, or dysmetabolic syndrome (eg, 
diabetes) were excluded, as were pregnant women. Patients 
with severe cutaneous disorders or a negative skin reaction 
to histamine and those treated with drugs that might interfere 
with a cutaneous response were not tested. Reported 
symptoms (rhinitis, conjunctivitis, cough, and asthma) and 
the season they appeared or worsened were also recorded. 
Furthermore, the Italian Aerobiology Association (which 
coordinates the monitoring of aerobiological and airborne 
pollen concentration in Italy) provided us with data on 
airborne cypress pollen concentrations during 1998-2000 
and 2010-2012 so that we could determine whether these 
pollen concentrations had changed over time. For the purpose 
of this study, all data (sensitizations, symptoms, seasons, 
and pollen concentrations) were classified based on area 
of origin (southern, central, and northern Italy). Patients 
were then classified as cypress-sensitized (polysensitized 
plus monosensitized), non–cypress-sensitized (sensitized 
to other allergens), and cypress-monosensitized in order to 
evaluate whether there were differences in symptoms and 
their seasonality. A χ2 test was used to compare sensitizations, 
symptoms, and seasonality of symptoms.
n Resumen
Antecedentes: Se trata de una encuesta multicéntrica realizada en Italia para evaluar el impacto de la sensibilización a polen de ciprés en 
sujetos atópicos y establecer si la concentración de este polen en el aire ha cambiado a lo largo del tiempo.
Métodos: El estudio fue realizado por alergólogos que recopilaron 100-200 sujetos consecutivos con pruebas cutáneas positivas (Prick) 
realizadas en 2012. Se recogieron los síntomas estacionales, junto con la concentración de polen de ciprés (obtenida por la asociación 
italiana de aerobiología) en 1998-2000 y 2010-2012.
Resultados: En cuanto a los resultados obtenidos fueron examinados 2258 pacientes atópicos (56% mujeres; edad 2-84), sensibilizados 
frente al menos uno de los aeroalérgenos testados (Dermatophagoides, gramíneas, parietaria, olivo, cipres, abedul, Alternaria tenuis y 
epitelio de gato). El 62.9%, 16.1% y 32.7% de los pacientes que vivían en el centro, norte y sur de Italia, respectivamente, mostraron 
sensibilización a polen de ciprés (p<0.0001). Observamos un pico de concentración de polen de ciprés de febrero a marzo en los años 
1998-2000 y 2010-2012, en todas las áreas. Los pacientes monosensibilizados a ciprés mostraron de forma prevalente rinitis (90.7-97.6%) 
y conjuntivitis  (38.1-100%). La prevalencia de rinitis , conjuntivitis y asma se incrementa progresivamente (p<0.0001) del sur hacia el 
norte de Italia en los sujetos polisensibilizados. La misma tendencia se observó en los síntomas invernales típicos de la alergia al ciprés. 
Conclusiones: En conclusión, actualmente el polen de ciprés es el aeroalérgeno sensibilizante más frecuente (según resultados de prueba 
cutánea) en varias áreas de Italia central. Las variaciones del periodo de polinización pueden favorecer el incremento observado en la 
sensibilización a este polen. Los síntomas predominantes son rinitis y conjuntivitis. El impacto clínico de esta alergia es pobre en áreas del 
sur de Italia, siendo alto en las áreas del norte.
Palabras clave: Anafilaxia. Hipersensibilidad a medicamentos. Encuesta portuguesa.
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Results
The results are summarized in the Figures and Table. In most 
areas of central Italy, cypress is the most common sensitizing 
allergen—as assessed using SPTs—with a mean prevalence of 
62.9% among 782 patients sensitized to at least 1 of the common 
aeroallergens tested (Figures 1 and 2). In northern Italy, however, 
sensitization was less prevalent (16.1% of 771 subjects). In 
southern Italy, prevalence was intermediate (32.7% of 705 
subjects) (Figures 1 and 2). Therefore, the mean prevalence 
was higher in central Italy (P<.0001; χ2 test, Figure 2). Cypress 
was the main sensitizing allergen in some Italian central areas 
(Figure 1). The prevalence of grass and olive sensitization was 
also higher in this region, although sensitization to cat and 
dog dander was more prevalent in northern Italy (Figure 2). 
Variations in the mean cypress pollen concentrations were found 
in the different areas (Figure 3). The pollen concentration peak 
was clearly delayed from February to March during both study 
periods (1998-2000 and 2010-2012) in all 3 regions, with a shift 
in pollination towards spring. Only a small number of sensitized 
patients (17.2%) were monosensitized, and the largest number 
were located in southern Italy (Table). Rhinitis was the most 
frequent symptom reported by monosensitized patients in all 3 
Figure 1. Geographic distribution of the centers showing the percentages 
of patients with a positive skin prick test result to cypress. In some cities, 
the prevalence of sensitization to cypress was particularly high. These 
cities are marked in bold. SPT indicates skin prick test; C indicates cypress.
Table. Symptoms and Seasons When They Appeared, as Reported by Patients Living in Southern, Central, and Northern Italy
   Southern Italy (705 Patients)   Central Italy (782 Patients)  Northern Italy (771 Patients) 
 CS Non-CS Mono-CS Pa CS Non-CS Mono-CS Pa CS Non-CS Mono-CS Pa Pb Pc
Total 231  474 84 .0001 492 290 54 .0001 123 648 8 .0001 .0001 .0001 
 (32.8%) (67.2%) (11.9%)  (62.9%) (37.1%) (6.9%)  (16%) (84%) (1%)
Rhinitis 86 247 82 .0002 366 232 49 .49 118 457 8 .0001 .0001 .0001 
 (37.2%) (52.1%) (97.6%)  (74.4%) (80%) (90.7%)  (95.9%) (70.5%) (100%) 
Conjunctivitis 72 292 32 .0001 230 144 28 .23 92 364 8 .0001 .0001 .0002 
 (31.1%) (61.6%) (38.1%)   (46.7%) (50%) (68.5%)  (74.8%) (56.2%) (100%) 
Cough 63 53 26 .0001 75 76 20 .0002 8 30 0 .37 .0001 .0001 
 (27.3%) (11.2%) (31%)  (15.2%)  (26.2%) (37%)  (6.5%) (4.6%) 
Asthma 29 51 11 .48 111 83 11 .18 44 131 0 .0002 .0001 .0001 
 (12.5%) (10.7%) (13.1%)   (22.5%) (28.6) (20.3%)  (35.8%) (20.2%) 
Rhinitis  76 140 10 .36 131 92 12 .16 46 279 0 .24 .086 .0001 
plus asthma  (32.9%) (29.5%) (11.9%)  (26.6%) (31.7%)  (22.2%)  (37.4%) (43%) 
Perennial 92 204 15 .41 197 156 15 .003 91 404 0 .013 .0001 .0001 
symptoms  (39.8%) (43%) (17.8%)   (40%) (53.8%) (27.7%)  (74%) (62.3%) 
Winter 64 46 45 .0001 178 45 30 .0001 80 129 8 .0001 .0001 .0001 
symptoms (27.7%) (9.7%) (53.6%)   (36.2%)  (15.5%) (55.5%)  (65%) (19.9%) (100%) 
Spring 107 175 14 .016 246 149 14 .61 83 269 8 .0001 .0007 .004 
symptoms  (46.3%) (36.9%) (16.6%)  (50%) (51.3%) (25.9%)  (67.5%) (41.5%) (100%)
Summer/ 58 100 32 .23 90 61 2 .40 69 211 0 .0001 .0001 .0001 
autumnal (25.1%) (21.1%) (38%)  (18.3%) (21%) (3.7%)  (56%) (32.5%) 
symptoms
Abbreviations: CS, cypress-sensitized (both polysensitized and monosensitized) patients; Mono-CS, cypress-monosensitized patients; Non-CS,  
non–cypress-sensitized patients. 
Comparisons were made using the χ2 test.
P a, statistical analysis results of comparisons between CS and Non-CS subgroups.
P b, statistical analysis results of comparisons among CS patients from southern, central, and northern Italy.
P c, statistical analysis results of comparisons among Non-CS patients from southern, central, and northern Italy.
Northern Italy 
SPTs positive (n=771) 
C-positive: 16.08%
Central Italy
SPTs positive (n=782)
C-positive: 62.91%
Southern Italy
SPTs positive (n=705)
C-positive: 32.7%
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regions. Conjunctivitis was also a common symptom, although 
only in central and northern Italy. In contrast, asthma was less 
frequent. The distribution of reported symptoms and their 
seasonality differed both for cypress-sensitized and non–cypress-
sensitized patients in all 3 areas (Table). When we compared 
all cypress-sensitized patients with non–cypress-sensitized 
patients, we found that rhinitis and conjunctivitis (typical of 
sensitization to cypress) were less prevalent in southern Italy in 
the first group (P<.0001) and more prevalent in northern Italy 
(P<.0001). In contrast, no differences were found for rhinitis 
and conjunctivitis in central Italy (P=.23). The prevalence of 
rhinitis and conjunctivitis increased progressively with latitude. 
In fact, patients from southern Italy had fewer symptoms than 
patients from central and northern Italy, especially in the case 
of cypress-sensitized patients (P<.0001). Cough was more 
frequent among cypress-sensitized patients in southern Italy 
(P<.0001) and among non–cypress-sensitized patients in central 
Italy (P=.0002). Furthermore, cough was more common among 
cypress-sensitized patients in southern Italy than in central Italy 
and northern Italy (P<.0001). No significant differences in the 
prevalence of asthma were reported between cypress-sensitized 
and non–cypress-sensitized patients. Comparison by area, on the 
other hand, revealed that the number of asthmatics increased 
progressively, with lower values in southern Italy, higher values 
in central Italy, and the highest values in northern Italy, especially 
among cypress-sensitized patients. A larger number of cypress-
sensitized patients than non–cypress-sensitized patients reported 
typical winter cypress allergy symptoms in all the areas studied 
(P<.0001). The prevalence of winter and spring symptoms 
increased progressively with latitude: lower values were found 
in the south, higher ones in the center, and the highest values in 
the north, especially in cypress-sensitized patients (P<.0001).
Discussion
The prevalence of sensitization to cypress pollen was 
highest in the center of Italy. The next most common 
sensitization was to Dermatophagoides species and grass 
pollen, which have traditionally been the most common 
allergens. Using the immunosolid phase allergen chip 
(ISAC) microarray system, Scala et al [7] found that, of 
23 077 unselected consecutive individuals with allergic 
diseases (mainly from Lazio and Central Italy), 42.7% were 
sensitized to Cup a 1, 38.7% to Der f 2, and 37.9% to Phl p 1. 
The prevalence of positive SPT results for the diagnostic panel 
varied with the region studied: northern, 16.1%; central, 62.9%; 
and southern, 32.7%. These differences are identical to those 
recorded over 10 years ago, when the prevalence of sensitization 
to Cupressaceae (positive skin test results) was 9.2% (north), 
28.2% (center), and 20.1% (south) [3]. These results were also 
confirmed using the ISAC test in a study of 55 000 patients 
that revealed a greater prevalence of sensitization to cypress 
in Lazio and Umbria (central Italy) and a lower prevalence 
of sensitization in Lombardia (northern Italy) [8]. Prevalence 
has increased progressively and is now significantly higher 
in all Italian areas than it was 10 years ago [3]. Indeed, in the 
early 1990s, only 4%-10% of 49 660 patients with pollinosis 
throughout Italy were sensitized to Fagaceae, Cupressaceae, 
and Plantago [9].
This higher prevalence is generally attributed to increased 
exposure to pollen over time [1,2,4,5,10]. Cupressus 
sempervirens is particularly widespread in central Italy 
(especially Tuscany and Umbria) and is mainly used for 
ornamental purposes. However, no significant differences were 
observed in airborne cypress pollen concentrations measured 
in 2 different 3-year periods separated by 10 years between 
Figure 3. Mean values of airborne cypress pollen concentrations (grains/m3) measured between December and April of the 3-year periods studied (1998-
2000 and 2010-2012) in northern, central, and southern Italy.
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Figure 2. Prevalence of sensitization to various common aeroallergens, 
according to skin prick test results, in northern, central, and southern 
Italy. Comparisons between northern, central, and southern areas for 
each allergen tested (P<.0001; χ2 test).
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profilins. Therefore, only some asymptomatic patients seem not 
to be sensitized to the main allergens of cypress (eg, Cup a 1), 
even if they do show cross-reactivity to common or similar 
panallergens from taxonomically unrelated pollen families. In 
particular, olive and grass pollens contain allergens—Ole e 2, 
Phl p 12 (profilin), and Phl p 7 (calcium-binding protein)—
that can cross-react with pollens from unrelated species 
[17,19,20] and probably also with the Cupressaceae family. 
Some calcium-binding proteins (Cry j 4, Jun o 2, Jun o 4, and 
Cup a 4), profilins (Cup s 8), and thaumatins (Cup a 3, Cry j 3, 
Cup s 3, Jun a 3) from Cupressaceae species [8] might have 
molecular characteristics that are similar to those of other 
unrelated pollen panallergens, and this may be the reason for 
cross-reactivity. In fact, Cup a 4 (calcium-binding protein), a 
recently identified allergen from Cupressus arizonica, shows 
structural similarities to other calcium-binding allergens such 
as Ole e 3, Ole e 8, and Phl p 7 [21]. Furthermore, there is 
evidence that sensitization to pollens has become more frequent 
over time, especially in urban areas [11,22]. Cross-reactivity 
between panallergens may also have increased over time: in 
addition to more frequent sensitization to cypress, we found a 
more significant prevalence of grass and olive sensitization in 
central Italy than in other areas. Consequently, we hypothesize 
that there is greater cross-reactivity between these species of 
plants owing to more frequent sensitization to olive and grass 
pollen rather than to cypress pollen. This potentially increased 
cross-reactivity between the various allergenic components of 
pollen extracts could also be the cause of increased cypress 
sensitization. However, since cypress extract seems to have a 
low profilin and polcalcin content [18], cross-reactivity may 
not be the only explanation for the differences observed. 
Variations in prevalence and clinical impact can also be 
explained by differences in climate between the 3 regions. In 
fact, on the basis of our results, sensitization to cypress, especially 
when associated with other types of sensitization, seems to affect 
symptoms and their seasonality differently in the 3 regions studied. 
The prevalence of winter and spring symptoms, and of rhinitis and 
conjunctivitis in particular, increased progressively in southern, 
central, and northern Italy, especially in cypress-sensitized 
patients. The same trend was observed for asthma. In contrast, 
cough was more common among cypress-sensitized patients 
in southern Italy than in central and northern Italy. Therefore, 
the clinical impact of sensitization to cypress in polysensitized 
patients varies with latitude: poor in the south, intermediate in the 
center, and high in the north. The opposite trend was observed 
for cough. Differences are observed not only in the prevalence 
of symptoms, but also in the kind of cypress-induced symptoms 
at different latitudes, which could in turn be due to differences in 
the species of cypress planted, rain and wind patterns, humidity 
and temperature, degree of air pollution, plant distribution, load 
of other allergens during pollination, and the associations between 
allergens in the 3 regions (eg, grass in the north and pellitory in 
the south) [10,11,23]. These differences may also explain the 
dissimilar prevalence of sensitization in the 3 regions.
In conclusion, today, cypress pollen is the most frequent 
sensitizing aeroallergen detected using skin prick tests in 
central Italy. The variations in time of cypress pollination may 
have favored the increased prevalence of this sensitization. 
Rhinitis and conjunctivitis are the predominant symptoms, 
whereas asthma is less frequent. The clinical impact of cypress 
northern, central, and southern Italy (Figure 3). Therefore, 
the increase in airborne pollen concentration alone may not 
be sufficient to explain this significant increase in cypress 
sensitization. However, remarkable variations in airborne pollen 
concentrations can be observed between different sites in the 
same region; therefore, a mean pollen concentration may not be 
representative of a specific area. In contrast, our data on airborne 
pollen concentrations highlighted how cypress flowering is 
delayed (late winter/early spring) in the second 3-year period 
compared with the first one. In fact, the peak airborne cypress 
pollen concentration was observed in February in 1998-2000 
and in March in 2010-2012. Moreover, it was associated with a 
further increase in April. Climate changes in recent years may be 
responsible for these differences in pollination times and could 
have favored the increase in sensitization to cypress. Indeed, one 
study revealed a progressive increase in the duration of pollen 
seasons (Parietaria, olive, cypress) over a 27-year period, with 
a consequent increase in the percentage of individuals sensitized 
to the pollens. Again, this increase may have been the result 
of climate change, in particular, an increase in temperature 
[10] that was most likely a consequence of increased urban 
air pollution [11].
The presence of other species belonging to the Cupressaceae 
family, such as Juniperus oxycedrus and Juniperus communis, 
which flower earlier and later, respectively, could further 
extend the cypress pollen season [4,12]. Moreover, the 
persistence of old cypress pollen in the environment could 
prolong exposure, thus favoring sensitization. In fact, the in 
vivo and in vitro allergenic activity of cypress pollen persists 
for years after its collection [13].   
We found that rhinitis and conjunctivitis were the most 
prevalent symptoms in monosensitized patients; asthma was 
less frequent in this group, consistent with the findings of other 
studies [3,4]. This observation is probably due to the large 
aerodynamic size of cypress pollen grains (20-30 µm), which 
do not reach the lower airway, as they become trapped in the 
nasal or nasopharyngeal mucous membranes, thus causing 
mainly rhinitis and conjunctivitis [1]. Furthermore, the clinical 
impact of this sensitization is felt in winter, when cypress 
blooms, causing typical symptoms in almost all monosensitized 
patients, whereas polysensitized patients were less affected. 
In fact, when we analyzed southern, central, and northern 
Italy separately, 28%, 30%, and 65% of patients sensitized to 
cypress pollen (and other allergens) reported symptoms during 
the pollen season, thus confirming that cypress causes typical 
winter symptoms only in some polysensitized patients, as shown 
elsewhere [4,14]. In polysensitized patients without typical 
winter symptoms, cypress sensitization could be the result 
of—albeit partially—IgE cross-reactivity to proteins/epitopes 
with structures similar to those of allergens used in other pollen 
extracts belonging to taxonomically different plants [15]. IgE 
antibodies against a given allergen may bind to homologous 
molecules of panallergens (profilin, calcium-binding protein, 
lipid transfer protein, thaumatin-like protein) in different plant 
species [16,17]. In fact, in polysensitized patients, the use of 
allergen extracts to detect pollen sensitization through SPTs 
often points to cosensitization rather than cross-sensitization 
due to panallergens. Barber et al [18] found double the number 
of sensitizations to major allergens identified with SPT in 
patients who were simultaneously sensitized to polcalcins and 
B Sposato, et al.
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on symptoms is lower in polysensitized patients, although it 
differs with latitude: poor in the south, intermediate in the 
center, and high in the north. These variations must be taken 
into account to ensure optimal management of patients. 
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